SEC Comment Letter for AEHR TEST SYSTEMS (AEHR) (CIK 0001040470) (AEHR) — Feb 1, 2005
AEHR TEST SYSTEMS (AEHR) (CIK 0001040470)
Date: Feb. 1, 2005 · CIK: 0001040470 · Accession: 0000000000-05-005185
AI Filing Summary & Sentiment
File numbers found in text: 000-22893
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Mail Stop 0306
February 1, 2005
Via: US Mail and Facsimile to (510) 623-9686
Mr. Gary L. Larson
Vice President of Finance and Chief Financial Officer
Aehr Test Systems
400 Kato Terrace
Fremont, CA 94539
RE: Aehr Test Systems
Form 10-K for the fiscal year ended May 31, 2004
Form 10-Q for the quarter ended August 31, 2004
Form 10-Q for the quarter ended November 30, 2004
File No. 000-22893
Dear Mr. Larson:
We have reviewed your filing and have the following
comments.
We have limited our review to only your financial statements and
related disclosures and will make no further review of your
documents. Where indicated, we think you should revise your
document
in future filings in response to these comments. If you disagree,
we
will consider your explanation as to why our comment is
inapplicable
or a revision is unnecessary. Please be as detailed as necessary
in
your explanation. In some of our comments, we may ask you to
provide
us with supplemental information so we may better understand your
disclosure. After reviewing this information, we may or may not
raise additional comments.
Please understand that the purpose of our review process is
to
assist you in your compliance with the applicable disclosure
requirements and to enhance the overall disclosure in your filing.
We look forward to working with you in these respects. We welcome
any questions you may have about our comments or on any other
aspect
of our review. Feel free to call us at the telephone numbers
listed
at the end of this letter.
Form 10-K for the fiscal year May 31, 2004
Item 7. Management`s Discussion and Analysis of Financial
Condition
and Results of Operations - Pages 13-27
Results of Operations
Net sales - Page 16
1. When you cite more than one factor in explaining the change in
a
financial statement line item, the amounts of the individual
factors
cited, including offsetting factors, should be separately
quantified.
For example, revise future filings to quantify the amount of
increase
in sales of MTX and related products. In addition, each
significant
factor that contributed to the significant variances in net sales,
gross profit and the expense amounts should also be quantified and
discussed. We see that you have not consistently identified and
discussed reasons for changes in financial statement line items.
Please apply throughout MD&A to the extent practicable in future
filings.
2. Supplementally and in future filings provide more details of
the
reason that the increase in net sales related to the turnkey
project
that includes a significant pass-through component resulted in
lower
gross profit margins. More details should be provided of the
declining trend in gross profit margins and whether this is
expected
to continue.
Liquidity and Capital Resources - Page 17
3. We note that your accounts receivable balances increased
significantly for the fiscal year ended 2004 when compared with
the
year ended 2003. Revise future filings to discuss the reasons for
the significant increases in the 2004 balances and the resulting
impact as a source or use of your cash. In addition, the
significant
variances in the balance sheet amounts should also be discussed in
future filings.
4. Revise future filings to disclose your capital resources
commitments as of the end of the fiscal year, and the anticipated
funding sources. Refer to Item 303(2) of Regulation S-K.
Financial Statements
Consolidated Statements of Operations - Page 31
5. We note on page 5 that you license the "Test Fixture" products
to
others to manufacture and sell. We also note that the royalty
revenues account for about 16 percent of your net sales. Revise
future filings of your consolidated statements of income to
separately disclose revenues from the sale of products, services,
rental, royalties and other products if the revenues from any
individual referenced component are more than 10 percent of total
revenues for the year. Related costs and expenses should also be
disclosed separately. Refer to Rule 5-03(b)(1) and (2) of
Regulation
S-X.
Notes to Consolidated Financial Statements:
Note 1: Summary of Significant Accounting Principles and Policies
Revenue Recognition - Page 35
6. We see that you recognize revenue when products are shipped and
that some revenues are deferred for products or services subject
to
acceptance provisions. We also see on page 5 that your sales are,
in
part, made through distributors. Revise and expand future filings
to
address the following:
a. Description of the significant terms of your arrangements with
distributors, including but not limited to pricing, payment and
return policies;
b. Demonstration that revenue recognition at shipment is
appropriate
for transactions with distributors;
c. Clarify the accounting for any special arrangements with
distributors such as price protection, service contracts, rights
of
return and other discounts, credits or special terms.
d. How you considered paragraph 6 of SFAS 48;
e. Whether your arrangements with these distributors or any other
parties ever include vendor consideration as described in EITF 01-
09;
f. Description of the nature and extent of the EITF 01-09
consideration and how you accounted for it.
7. Supplementally and in future filings provide details of whether
the Company`s products and services have multiple deliverables and
clarify the accounting treatment under EITF 00-21.
Note 13 - Segment Information - Page 45
8. You disclose that you operate in one industry segment. Do you
mean
one reportable segment pursuant to SFAS 131? Tell us how you
applied
the guidance of paragraphs 10 through 24 of SFAS 131.
Form 10-Q for the periods ended August 31, 2004 and November 30,
2004
9. You should consider the comments on the Form 10-K when
preparing
future Forms 10-Q.
* * * *
As appropriate, please respond to these comments within 10
business days or tell us when you will provide us with a response.
Please furnish a cover letter with your response that keys your
responses to our comments and provides any requested supplemental
information. Detailed cover letters greatly facilitate our
review.
Please file your cover letter on EDGAR. Please understand that we
may have additional comments after reviewing your responses to our
comments.
We urge all persons who are responsible for the accuracy and
adequacy of the disclosure in the filings reviewed by the staff to
be
certain that they have provided all information investors require.
Since the company and its management are in possession of all
facts
relating to a company`s disclosure, they are responsible for the
accuracy and adequacy of the disclosures they have made.
In connection with responding to our comments, please
provide,
in writing, a statement from the company acknowledging that
* the company is responsible for the adequacy and accuracy of the
disclosure in the filings;
* staff comments or changes to disclosure in response to staff
comments in the filings reviewed by the staff do not foreclose the
Commission from taking any action with respect to the filing; and
* the company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the
federal securities laws of the United States.
In addition, please be advised that the Division of
Enforcement
has access to all information you provide to the staff of the
Division of Corporation Finance in our review of your filing or in
response to our comments on your filing.
You may contact Patrick Enunwaonye, Staff Accountant, at
(202)
824-5529 or me, at (202) 942-1791 if you have questions regarding
comments on the financial statements and related matters. In this
regard, do not hesitate to contact Martin James, Senior Assistant
Chief Accountant, at (202) 942-1984 with any other concerns.
Sincerely,
Brian Cascio
Accounting Branch Chief
??
??
??
??
Mr. Gary L. Larson
Aehr Test Systems
February 1, 2005
Page 1 of 5
</TEXT>
</DOCUMENT>